Preview

Health and Ecology Issues

Advanced search

BACTERICIDAL PROPERTIES OF FLUOROQUINOLONE-CONTAINING EYE DROPS

https://doi.org/10.51523/2708-6011.2014-11-1-20

Abstract

Goal: to find out antimicrobial efficacy of ophthalmologic drugs containing fluoroquinolons of II-III generations. Material and methods. Minimal inhibitory concentrations for isolates of Staphylococcus aureus and Pseudomonas aeruginosa were determined for four drugs containing fluoroquinolons of II-III generations. The kinetics of growth and dying off of the test-culture of Pseudomonas aeruginosa ATCC 27853 under different fluoroquinolon concentration were performed in nutrient broth medium. Results. The minimal inhibitory concentrations for various drugs ranged from 0,125 to 1,0 mcg/ml. In relation to the test-cultures of Staphylococcus aureus , III generation fluoroquinolones (levofloxacin MIC 0,25-0,5 mcg/ml) were the most active. Ciprofloxacin was the most active against Pseudomonas aeruginosa (MIC 0,125 mcg/ml). It was shown that the bacterial effect of all the fluoroquinolones depends directly on the concentration of antibiotic in the medium. Conclusion. The antimicrobial activity of II-III generation fluoroquinolones from different producers was similar. The concentration of fluoroquinolones in the studied drugs makes it possible to achieve the bactericidal effect for sensitive gram-negative strains, even after short-term exposure. It is preferable to use III generation fluoroquinolones to treat for infections caused by gram-positive microorganisms

About the Authors

D. V. Tapalskiy
Gomel State Medical University
Belarus


N. Yu. Boitsova
Gomel State Medical University
Belarus


L. V. Dravitsa
Gomel State Medical University
Belarus


References

1. Практическое руководство по антимикробной химиотерапии / под ред. Л. С. Страчунского, Ю. Б. Белоусова, С. Н. Козлова. - Смоленск: МАКМАХ, 2007. - 464 с.

2. Drlica, K. Mechanism of fluoroquinolone action / K. Drlica // Current Opinion in Microbiology. - 1999. - Vol. 2. - P. 504-508.

3. Ogawa, G. S.The fluoroquinolones: New antibiotics in ophthalmology / G. S. Ogawa, R. A. Hyndiuk // International Ophthalmology Clinics. - 1993. - Vol. 33. - P. 59-68.

4. Pan, X. S. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance / X. S. Pan, L. M. Fisher // Journal of Bacteriology. - 1996. - Vol. 178. - P. 4060-4069.

5. Goldstein, M. H. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review / M. H. Goldstein, R. P. Kowalski, Y. J. Gordon // Ophthalmology. - 1999. - Vol. 106, № 7. - P. 1313-1318.

6. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones / A. Graves [et al.] // Cornea. - 2001. - Vol. 20, № 3. - P. 301-305.

7. Davis, R. Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy / R. Davis, H. M. Bryson // Drugs. - 1994. - Vol. 47. - P. 677-700.

8. North, D.S. Levofloxacin, a second-generation fluoroquinolone / D.S. North, D.N. Fish, J.J. Redington // Pharmacotherapy. - 1998. - Vol. 18. - P. 915-935.

9. Fish, D. N. Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs / D. N. Fish, M. K. Choi, R. Jung // Journal of Antimicrobial Chemotherapy. - 2002. - Vol. 50. - P. 1045-1049.

10. Burgess, D. S. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill / D. S. Burgess, R. W. Hastings // Diagnostic Microbiology and Infectious Disease. - 2000. - Vol. 38. - P. 37-41.


Review

For citations:


Tapalskiy D.V., Boitsova N.Yu., Dravitsa L.V. BACTERICIDAL PROPERTIES OF FLUOROQUINOLONE-CONTAINING EYE DROPS. Health and Ecology Issues. 2014;(1):107-110. (In Russ.) https://doi.org/10.51523/2708-6011.2014-11-1-20

Views: 221


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2220-0967 (Print)
ISSN 2708-6011 (Online)